Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
The 29th edition of Expomed Eurasia took place on March 17-19, 2022 in Istanbul, Turkey. With 600+ exhibitors from Turkey and around world & 19000 visitors only from Turkey and 5000 intern...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
Era Biology will host a global live webinar on November 29th 2022 22:00 (GMT +08:00). The webinar will talk about complete solutions for aspergillus galactomannan tests.
Aspergillus is often not sp...
A new starting point for the industry standard
Following YY/T 1729-2020 “Fungi (1-3)-β-D glucan determination kit”, YY/T 1793-2021 “Bacterial Endotoxin Determination Kit” fo...